Latest Technology News

Credit Corp Group delivered a robust FY25 with a 16% increase in net profit after tax, driven by US debt buying and Australian/NZ lending growth. The company sets an ambitious FY26 outlook, underpinned by a record US investment pipeline and new product launches.

TPG Telecom has unveiled pro forma financials reflecting its recent fibre network sale to Vocus, alongside updated FY25 guidance projecting EBITDA between $1.6 billion and $1.65 billion. The company signals a strategic pivot with fresh investments in satellite technology and IT systems.

Noxopharm’s Sofra™ technology shows promising results in collaboration with US biotech Tezcat Biosciences, advancing targeted drug delivery for cancer and inflammatory diseases.

Reckon Limited has reported a robust first half of 2025, marked by significant revenue and profit growth fueled by organic expansion and the acquisition of Cashflow Manager. The company’s cloud-based Reckon One product and US-focused Legal Group continue to drive momentum.

Reckon Limited has delivered a robust half-year performance with a 16% revenue increase and a 29% rise in net profit attributable to members, while declaring a steady fully franked dividend. Despite these gains, the company’s net tangible assets per share remain negative, highlighting ongoing balance sheet pressures.

Vitrafy Life Sciences announces a leadership change with CEO Kate Munnings retiring and co-founder Brent Owens stepping up to lead the company’s next growth phase.

Weebit Nano has appointed seasoned ASX director Anne Templeman-Jones as Deputy Chair, aiming to strengthen its engagement with Australian investors and government amid plans for growth.

Domain Holdings Australia has confirmed a one-week delay in the implementation of its proposed CoStar scheme of arrangement, now set for 27 August 2025.

Pinnacle Minerals Ltd is set to raise an additional $440,000 through a third tranche placement, aiming to accelerate its exploration programs and pursue new opportunities. This move follows strong investor demand and awaits shareholder approval.

Shift4 Payments has secured Overseas Investment Office approval for its NZ$1.20 per share acquisition of Smartpay, advancing the proposed scheme of arrangement closer to completion.

Alterity Therapeutics faces ASX scrutiny after mistakenly marking multiple announcements as market sensitive, prompting a review of its disclosure practices. The biotech denies any intent to manipulate its share price despite repeated errors.

Domain Holdings Australia Limited shareholders have overwhelmingly approved the proposed acquisition by CoStar Group, marking a pivotal step toward the deal’s completion pending court approval.